Cure 51
Cancer target discovery platform using exceptional survivor biology for pharmaceutical and oncology research partners
Highlights
- Young companyFounded 2022
- Hiring1 open role
- New on EvolcAdded 2026-10-30
About Cure 51
Cure51 is a tech-bio company that identifies and studies long-term cancer survivors, building clinical and multi-omics datasets to find therapeutic targets. Its Target ID program analyzes survivor cohorts and provides target shortlists and validation packages.
Pharmaceutical companies and oncology research partners can query Cure51’s cohorts and collaborate on target discovery and development. The company also develops precision medicine tools and works with cancer centers and laboratory partners.
Founded in 2022, Cure51 is headquartered in Paris. Its team works across science, computational biology, engineering, product, and clinical research; the careers page lists a computational biologist opening in Paris.
Product: Cancer target discovery services and a platform analyzing clinical and multi-omics data from exceptional survivor cohorts.
Jobs at Cure 51 (1)
Cure 51 is hiring for one role in data & AI, based in Paris.
PhD-level Computational Biologist
Young companyNew on Evolc
Companies hiring like Cure 51
Leadership
- PALOMA CEJAS · Late Founder Head of Translational ResearchSource: company website
- SIMON ISTOLAINEN · Co-Founder Chief Strategy OfficerSource: company website
- NICOLAS WOLIKOW · Co-Founder CEOSource: company website
- David Ouaknine · Chief Financial OfficerSource: company website
- EL MEHDI OUZGANE · Late Founder COOSource: company website
- ERIC DELALOY · Head of DesignSource: company website
- LOUIS BAPTISTE FRANCE · Head of EngineeringSource: company website
- MARINE OTÉRO DEL VAL · Head of ProductSource: company website
More biotech & pharma companies
Cytoo
Muscle disease drug-discovery services and micropattern products for pharmaceutical, biotechnology and research organizationsNew on EvolcDBV Technologies
Develops VIASKIN epicutaneous immunotherapy patches for patients with food allergies and other immunological diseasesNew on EvolcDeeplife
AI-driven cell digital twins and multi-omics analysis for pharmaceutical drug discovery and developmentNew on EvolcDepixus
Magnetic force spectroscopy instruments for researchers studying biomolecular interactions and drug discoveryNew on EvolcDiogenx
Preclinical biotech developing regenerative protein therapies for type 1 diabetes, aimed at restoring insulin-producing beta cellsNew on EvolcDiscngine
Scientific software and custom IT services for life science research and early drug discovery teamsNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Framer
- Google Analytics 4
- Matomo